Scientist says India can increase production of 'arhar dal' three times

The pigeonpea (Cajanus cajan) is a major source of protein for the population of the Indian subcontinent.

Devdiscourse News Desk | Hyderabad | Updated: 25-10-2018 23:43 IST | Created: 25-10-2018 16:18 IST
Scientist says India can increase production of 'arhar dal' three times
The two-year project holds promise to improve livelihoods and nutrition security of the most- at-need communities in south-east Asia and in Africa. (Image Credit: Twitter)

India, the world's largest producer of pigeonpea or 'arhar dal', could increase the production of the grain by three times, say scientists who are working on creating varieties resistant to diseases and climate change.

The pigeonpea (Cajanus cajan) is a major source of protein for the population of the Indian subcontinent.

Pre-breeding scientists at the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) are exploring possible solutions sourced from the wild species of Cajanus.

A project funded by the Global Crop Diversity Trust (GCDT), will evaluate promising pre-breeding lines in India and Myanmar, bringing them one step closer to cultivation.

"It is critical to bring in beneficial traits that are not present in domesticated pigeonpea, and the pre-breeding work at ICRISAT holds great promise," said Benjamin Kilian, Plant Genetic Resources Scientist from the GCDT.

"Our goal of increasing the livelihood and nutrition security of smallholder farmers moves forward, and pre-breeding has hastened the process of reaching better crop varieties to farmers," said Peter Carberry, Director General, ICRISAT.

It has taken several years of research for scientists to evaluate wild pigeonpea species and identify those with the promise of resistance/tolerance to biotic and abiotic stresses, including sterility mosaic disease, Fusarium wilt, pod borer and salinity.

"Pigeonpea has a narrow genetic base. The varieties currently grown by farmers have little resilience to recurrent or new diseases and insect pests," said Shivali Sharma, Principal Investigator at ICRISAT.

"We find some wild species have adapted to several of these stresses. Leveraging these traits for cultivation can benefit livelihoods and nutrition," said Sharma.

"This project will develop new material as well as take the available material to the farmers so that they can produce more and generate better incomes with the new climate-resilient pigeonpea varieties," said Rajeev K Varshney, Research Program Director - Genetic Gains at ICRISAT.

Field-level activities in multiple agro-ecologies and socio-economic settings (different locations) will be carried out by ICRISAT in collaboration with the following national and international partners.

The two-year project holds promise to improve livelihoods and nutrition security of the most- at-need communities in south-east Asia and in Africa.

(With inputs from agencies.)


TRENDING

OPINION / BLOG / INTERVIEW

Blockchain in Healthcare: Opportunities and challenges

The use of blockchain in healthcare is a relatively new innovation with many of its uses still being explored and related technologies being developed, improved, and scaled. ...

Debate surrounding vaccine passports and development misses bigger picture

... ...

Blockchain vs IOTA: Looking for a better alternative

... ...

For stability, Iraq needs to crack down on corruption

... ...

Videos

Latest News

Maharashtra govt extends lockdown-like restrictions in state till June 1: Official.

Maharashtra govt extends lockdown-like restrictions in state till June 1 Official....

India retain top spot in ICC Test Team rankings after annual update

India remained the number one Test side after the annual update of the ICC team rankings, released on Thursday.India head the table after gaining one rating point for an aggregate of 121, having accumulated 2914 points from 24 matches.Virat...

50 employees of Bharat Biotech test COVID-19 positive; Joint MD's tweet draws bouquets and brickbats

Eds Adds word in headline Hyderabad, May 13 PTI Bharat Biotechs Joint Managing Director Suchitra Ellas tweet saying 50 of their employees tested positive for COVID received bouquets and brickbats from netizens with some saying Covaxin was s...

Increase gap between two doses of Covishield to 12-16 weeks, pregnant women can choose vaccine:Panel

A government panel has recommended increasing the gap between two doses of Covishield COVID-19 vaccine to 12-16 weeks, official sources said on Thursday.No change has been suggested for dosage interval of Covaxin by the National Technical A...

Give Feedback